Parry Graham reported ETRA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002153366-26-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 21, 2026

Published

Sep 21, 2026

Ingested by INSIDER

Nov 5, 02:16 UTC

Last re-read

Nov 5, 02:16 UTC

Extracted facts

Filer

Parry Graham

Role

Chief Scientific Officer

Transaction

Derivative conversionAs filed: “C”

Asset

Electra Therapeutics, Inc.

Ticker

ETRA

Shares

85.5K

Execution date (reported)

Sep 21, 2026

Owned after transaction

85.5K shares

Days from execution to publication

0

What this establishes

Parry Graham filed this Form 4 reporting a derivative conversion of ETRA on Sep 21, 2026. It became public on Sep 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Scientific Officer

Parry Grahamcik:0002153366

Issuer

Electra Therapeutics, Inc.cik:0002088082

Revision history · 0

No field has changed since this record was first ingested.